Soluble immune checkpoint molecules: mechanism of formation, function, role in malignant neoplasms
Immune checkpoints (ICs) represent a broad set of stimulatory and inhibitory signaling pathways playing an important role in regulation of immune responses. Initially, ICs have been considered solely as cell membrane-bound receptor and ligand systems, triggering or blocking immune cell function. Ove...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
2025-01-01
|
| Series: | Медицинская иммунология |
| Subjects: | |
| Online Access: | https://www.mimmun.ru/mimmun/article/view/2965 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849240780839845888 |
|---|---|
| author | T. V. Glazanova I. E. Pavlova E. V. Kuzmich L. N. Bubnova |
| author_facet | T. V. Glazanova I. E. Pavlova E. V. Kuzmich L. N. Bubnova |
| author_sort | T. V. Glazanova |
| collection | DOAJ |
| description | Immune checkpoints (ICs) represent a broad set of stimulatory and inhibitory signaling pathways playing an important role in regulation of immune responses. Initially, ICs have been considered solely as cell membrane-bound receptor and ligand systems, triggering or blocking immune cell function. Over the past decade they have been proven to exist in soluble forms (sICs). sICs are biologically active regulators involved in paracrine and systemic modulation of immune responses, similar to cytokines. Normally, sICs exert both stimulatory and inhibitory effects on the immune system, and their balance may be disturbed in many malignant neoplasms, COVID-19, HIV infection. There is a lot of data on the connection between sICs and various diseases, but a number of key aspects of their biology have not been fully clarified. The most widely studied are PD-1 (programmed death receptor-1) and its ligands PD-L1 and PD-L2, CTLA-4 (cytotoxic T lymphocyte antigen-4), TIM-3 (T cell immunoglobulin and mucin-domain containing-3), VISTA (V-domain Ig-containing suppressor of T cell activation). The mechanisms of soluble form formation are complex and diverse and include alternative splicing, cleavage of membrane ectodomains, and proteolytic cleavage. The most important molecular mechanisms underlying the synthesis and release of sPD-1 and sPD-L1 are alternative splicing of mRNA and translation of isoforms lacking transmembrane domains, while the formation of sTIM-3 occurs by cleaving the extracellular regions of transmembrane proteins by protease ADAM10. The review article provides data on the main sICs, including sPD-1, sPD-L1, exosomal sPD-L1, sCTLA-4, and several others. The molecular mechanisms of their formation, biological functions in maintaining immune homeostasis, prognostic significance of changes in their content are described in patients with solid malignant tumors (nonsmall cell lung cancer, hepatocellular cancer, breast cancer, kidney cancer, skin cancer, gastric cancer, etc.), as well as for hematologic malignancies (lymphoma, chronic lymphocytic leukemia, acute myeloblastic leukemia, multiple myeloma). |
| format | Article |
| id | doaj-art-17e54297be5c4cefa32f10a113cd0bef |
| institution | Kabale University |
| issn | 1563-0625 2313-741X |
| language | Russian |
| publishDate | 2025-01-01 |
| publisher | St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists |
| record_format | Article |
| series | Медицинская иммунология |
| spelling | doaj-art-17e54297be5c4cefa32f10a113cd0bef2025-08-20T04:00:26ZrusSt. Petersburg branch of the Russian Association of Allergologists and Clinical ImmunologistsМедицинская иммунология1563-06252313-741X2025-01-01271213410.15789/1563-0625-SIC-29651872Soluble immune checkpoint molecules: mechanism of formation, function, role in malignant neoplasmsT. V. Glazanova0I. E. Pavlova1E. V. Kuzmich2L. N. Bubnova3Russian Research Institute of Haematology and Transfusiology, Federal Medical and Biological AgencyRussian Research Institute of Haematology and Transfusiology, Federal Medical and Biological AgencyRussian Research Institute of Haematology and Transfusiology, Federal Medical and Biological AgencyRussian Research Institute of Haematology and Transfusiology, Federal Medical and Biological Agency; First St. Petersburg State I. Pavlov Medical UniversityImmune checkpoints (ICs) represent a broad set of stimulatory and inhibitory signaling pathways playing an important role in regulation of immune responses. Initially, ICs have been considered solely as cell membrane-bound receptor and ligand systems, triggering or blocking immune cell function. Over the past decade they have been proven to exist in soluble forms (sICs). sICs are biologically active regulators involved in paracrine and systemic modulation of immune responses, similar to cytokines. Normally, sICs exert both stimulatory and inhibitory effects on the immune system, and their balance may be disturbed in many malignant neoplasms, COVID-19, HIV infection. There is a lot of data on the connection between sICs and various diseases, but a number of key aspects of their biology have not been fully clarified. The most widely studied are PD-1 (programmed death receptor-1) and its ligands PD-L1 and PD-L2, CTLA-4 (cytotoxic T lymphocyte antigen-4), TIM-3 (T cell immunoglobulin and mucin-domain containing-3), VISTA (V-domain Ig-containing suppressor of T cell activation). The mechanisms of soluble form formation are complex and diverse and include alternative splicing, cleavage of membrane ectodomains, and proteolytic cleavage. The most important molecular mechanisms underlying the synthesis and release of sPD-1 and sPD-L1 are alternative splicing of mRNA and translation of isoforms lacking transmembrane domains, while the formation of sTIM-3 occurs by cleaving the extracellular regions of transmembrane proteins by protease ADAM10. The review article provides data on the main sICs, including sPD-1, sPD-L1, exosomal sPD-L1, sCTLA-4, and several others. The molecular mechanisms of their formation, biological functions in maintaining immune homeostasis, prognostic significance of changes in their content are described in patients with solid malignant tumors (nonsmall cell lung cancer, hepatocellular cancer, breast cancer, kidney cancer, skin cancer, gastric cancer, etc.), as well as for hematologic malignancies (lymphoma, chronic lymphocytic leukemia, acute myeloblastic leukemia, multiple myeloma).https://www.mimmun.ru/mimmun/article/view/2965immune checkpoint moleculessolubleformation mechanismspd-1spd-l1malignant neoplasmshematological malignancies |
| spellingShingle | T. V. Glazanova I. E. Pavlova E. V. Kuzmich L. N. Bubnova Soluble immune checkpoint molecules: mechanism of formation, function, role in malignant neoplasms Медицинская иммунология immune checkpoint molecules soluble formation mechanism spd-1 spd-l1 malignant neoplasms hematological malignancies |
| title | Soluble immune checkpoint molecules: mechanism of formation, function, role in malignant neoplasms |
| title_full | Soluble immune checkpoint molecules: mechanism of formation, function, role in malignant neoplasms |
| title_fullStr | Soluble immune checkpoint molecules: mechanism of formation, function, role in malignant neoplasms |
| title_full_unstemmed | Soluble immune checkpoint molecules: mechanism of formation, function, role in malignant neoplasms |
| title_short | Soluble immune checkpoint molecules: mechanism of formation, function, role in malignant neoplasms |
| title_sort | soluble immune checkpoint molecules mechanism of formation function role in malignant neoplasms |
| topic | immune checkpoint molecules soluble formation mechanism spd-1 spd-l1 malignant neoplasms hematological malignancies |
| url | https://www.mimmun.ru/mimmun/article/view/2965 |
| work_keys_str_mv | AT tvglazanova solubleimmunecheckpointmoleculesmechanismofformationfunctionroleinmalignantneoplasms AT iepavlova solubleimmunecheckpointmoleculesmechanismofformationfunctionroleinmalignantneoplasms AT evkuzmich solubleimmunecheckpointmoleculesmechanismofformationfunctionroleinmalignantneoplasms AT lnbubnova solubleimmunecheckpointmoleculesmechanismofformationfunctionroleinmalignantneoplasms |